🇺🇸 FDA
Patent

US 9556113

Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment

granted A61KA61K31/225A61K33/243

Quick answer

US patent 9556113 (Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment) held by SOUTH DAKOTA BOARD OF REGENTS expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SOUTH DAKOTA BOARD OF REGENTS
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/225, A61K33/243, A61K45/06, A61K47/02